Latest News in the pharma Industry

Market News

FDA approves Synjardy XR tablets for adults with type 2 diabetes

FDA approves Synjardy XR tablets for adults with type 2 diabetes

13 Dec 2016

New once-a-day formulation indicated to improve blood sugar when used along with diet and exercise.

Read more 
Perrigo to restructure its Branded Consumer Healthcare business

Perrigo to restructure its Branded Consumer Healthcare business

13 Dec 2016

Actions will help to improve the company's financial profile.

Read more 
Alvogen launches the first generic equivalent to Tamiflu capsules in the US

Alvogen launches the first generic equivalent to Tamiflu capsules in the US

12 Dec 2016

Company expects the generic capsules will save up to $500 million during this upcoming season.

Read more 
Arctic blast yields better lyophilisation results

"Arctic blast" yields better lyophilisation results

12 Dec 2016

Users of LyoSpeed on Series 3 HT Evaporators report a greater percentage of samples yield dry powders than they have previously been able to achieve.

Read more 
Lonza confirms interest in Capsugel

Lonza confirms interest in Capsugel

12 Dec 2016

Acquisition would "fit perfectly with Lonza's Healthcare Continuum strategy".

Read more 
Demand for safe packaging to combat illicit drug market rackets on the rise

Demand for safe packaging to combat illicit drug market rackets on the rise

12 Dec 2016

Pharma manufacturers are feeling encouraged to explore new possibilities.

Read more 
Novartis' Lucentis received EU approval in new indication

Novartis' Lucentis received EU approval in new indication

10 Dec 2016

Lucentis the only treatment available for a wide range of CNV conditions.

Read more 
Lilly and AstraZeneca to develop second potentially disease-modifying treatment for Alzheimer's

Lilly and AstraZeneca to develop second potentially disease-modifying treatment for Alzheimer's

10 Dec 2016

"MEDI1814 has a unique mechanism among antibodies in clinical development and could provide a distinct approach to treating Alzheimer's disease."

Read more 
Neurimmune and TVM Capital Life Science create AL-S Pharma

Neurimmune and TVM Capital Life Science create AL-S Pharma

10 Dec 2016

New company will develop, to proof-of-concept, AP-101, a human monoclonal antibody targeting misfolded SOD1 for the treatment of amyotrophic lateral sclerosis.

Read more 
Mederi's Stretta Therapy for GERD approved in China

Mederi's Stretta Therapy for GERD approved in China

9 Dec 2016

Clinically proven and cost-effective solution for gastroesophageal reflux disease recently launched in China.

Read more 
Leon-nanodrugs and Instillo work together to tackle formulations issues

Leon-nanodrugs and Instillo work together to tackle formulations issues

8 Dec 2016

MJR technology offers reformulation options that can lead to a superior profile for an API.

Read more 
Pfizer refutes the findings set out in the CMA decision

Pfizer refutes the findings set out in the CMA decision

8 Dec 2016

Pharma giant says it complied with established competition law.

Read more